Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2024-04-24 | Penser Access by Carnegie | Penser Access by Carnegie: Intervju med Diamyd Medical - Carnegie Investment Bank - 24 april 2024 | Pressreleaser | Visa Stäng |
|
||||
2024-04-24 | Penser Access by Carnegie | Penser Access by Carnegie: Diamyd Medical - Går en spännande framtid till mötes | Pressreleaser | Visa Stäng |
|
||||
2024-04-18 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical announces final outcome in the company's rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-18 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical offentliggör slutgiltigt utfall i bolagets företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-16 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical offentliggör preliminärt utfall i bolagets företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-16 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical announces preliminary outcome in the company's rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-12 | Penser Access by Carnegie | Penser Access by Carnegie: Intervju med Diamyd Medical - Carnegie Investment Bank - 12 april 2024 | Pressreleaser | Visa Stäng |
|
||||
2024-04-12 | Diamyd Medical | Diamyd Medical AB: Rekryteringsmilstolpe har uppnåtts i fas III-studie med Diamyd® | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-12 | Diamyd Medical | Diamyd Medical AB: Recruitment milestone reached in Diamyd® Phase 3 trial | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-11 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical led ASSET innovation partnership organizes a workshop on the future treatment of Type 1 Diabetes | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-11 | Diamyd Medical | Diamyd Medical AB: Innovationsmiljön ASSET, lett av Diamyd Medical, håller en workshop om framtidens behandling av typ 1-diabetes | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-05 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical's main Shareholders announce their subscription commitments in the ongoing rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-05 | Diamyd Medical | Diamyd Medical AB: Diamyd Medicals storägare meddelar teckningsåtagande i pågående företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-02 | Penser Access by Carnegie | Penser Access by Carnegie: Diamyd Medical - Fyller på kassan | Pressreleaser | Visa Stäng |
|
||||
2024-03-28 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical offentliggör prospekt avseende företrädesemissionen | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-28 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical publishes prospectus with regards to the rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-27 | Diamyd Medical | Diamyd Medical AB: Delårsrapport II 23/24 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-03-27 | Diamyd Medical | Diamyd Medical AB: Quarterly Report II 23/24 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-03-18 | Diamyd Medical | Diamyd Medical AB: Styrelsen i Diamyd Medical har beslutat om en företrädesemission om cirka 114 MSEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-18 | Diamyd Medical | Diamyd Medical AB: The Board of Directors in Diamyd Medical have resolved on a rights issue of approximately SEK 114 million | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Diamyd Medical AB: The Board of Directors in Diamyd Medical have resolved on a rights issue of approximately SEK 114 million”With the very positive development led by the granting of Fast Track status by the US FDA, this preferential rights issue further strengthens our strategic position,” says Ulf Hannelius, CEO of Diamyd Medical. ”By harmonizing with the existing warrant structure and upcoming key milestones, it provides opportunities for advantageous long-term financial planning.” Summary of the Rights Issue
Background and reason The great medical need and demand for new disease-modifying treatments for autoimmune diabetes is made clear by the partnership that Diamyd Medical entered into with the American patient organization JDRF in April 2023, as well as, market analysis from January 2024 that support premium pricing of Diamyd[® ]and a great willingness to prescribe the drug on the US market. In addition, in February 2024, the FDA granted Diamyd[®] Fast Track Designation for the treatment of new-onset type 1 diabetes. Diamyd Medical has a broad focus on preventive medicine through the registration-based precision medicine phase 3 study DIAGNODE-3, which is ongoing in eight European countries and in the US, the prevention study DiaPrecise, completion of the manufacturing facility, Diamyd Biomanufacturing, as well as market preparation regulatory and commercial activities. Use of issue proceeds
Preliminary timeline for the Rights Issue March 25, 2024 Last day of trading in B-shares including The above preliminary timeline is conditional on that the Prospectus is approved and can be published at the estimated date of March 28, 2024. Subscription commitments Exercise price and subscription period for warrants of series TO 4 Additional unit issue Shares and share capital Shareholders who choose not to subscribe in the Rights Issue will therefore be faced with a maximum dilution effect of approximately 9.1 percent of the number of shares and votes, calculated as new shares and votes divided by the total number of outstanding shares and votes after the Rights Issue, but are given the opportunity to be financially compensated for this dilution effect by selling their received unit rights of series B. If the Board of Directors of Diamyd Medical resolve on the additional unit issue and it is exercised and subscribed to the maximum amount possible, the number of B-shares will increase by 1,666,666 shares. Considering that the Rights Issue is fully subscribed, the total number of shares will thus increase by 1,666,666 shares, from 104,442,795 shares to 106,109,461 shares, of which 3,015,793 are A-shares and 103,093,668 are B-shares. Upon full exercise and subscription of the additional unit issue, the share capital will increase by SEK 169,035.365277, from SEK 10,592,719.839107 to SEK 10,761,775.2044, provided a fully subscribed Rights Issue. Shareholders would thereby experience a dilution effect of an additional maximum of approximately 1.6 percent of the number of shares and approximately 1.3 percent of the number of votes. Shareholders who choose not to subscribe in the Rights Issue may therefore experience a dilution effect of up to approximately 10.5 percent of the number of shares and approximately 10.2 percent of the total number of votes. Should the warrants be fully exercised (assuming full subscription in the Rights Issue and that all warrants of series TO 4 issued in connection with the rights issue in October 2023 are exercised), this would imply an additional dilution effect of approximately 8.7 percent of the number of shares and approximately 8.4 percent of the number of votes. Should the Board of Directors resolve on the additional unit issue, and it is exercised to the maximum extent possible, provided the Rights Issue is fully subscribed, the dilution effect resulting from the warrant series being fully exercised would instead amount to approximately 18.3 percent of the number of shares and approximately 17.8 percent of the number of votes. Prospectus Advisors About Diamyd Medical Diamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B. FNCA Sweden AB is the Company’s Certified Adviser. |
||||
2024-02-29 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical to present new genetic data at the ASIT summit in Boston, MA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-29 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical presenterar nya genetiska data på ASIT Summit i Boston | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-22 | Penser Access by Carnegie | Penser Access by Carnegie: Intervju med Diamyd Medical - Carnegie Investment Bank - 22 feb 2024 | Pressreleaser | Visa Stäng |
|
||||
2024-02-15 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical receives U.S. FDA Fast Track designation for Diamyd® | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-15 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical erhåller Fast Track designation för Diamyd® av den amerikanska läkemedelsmyndigheten FDA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-14 | Diamyd Medical | Diamyd Medical AB: Publication in Diabetologia highlights AI's potential for Type 1 Diabetes screening | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-14 | Diamyd Medical | Diamyd Medical AB: Publikation i Diabetologia belyser AI:s potential för screening av typ 1-diabetes | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-30 | Penser Access by Carnegie | Penser Access by Carnegie: Intervju med Diamyd Medical - Carnegie Investment Bank - 30 jan 2024 | Pressreleaser | Visa Stäng |
|
||||
2024-01-26 | Penser Access by Carnegie | Penser Access by Carnegie: Diamyd Medical - Alla ögon på DIAGNODE-3 | Pressreleaser | Visa Stäng |
|
||||
2024-01-24 | Diamyd Medical | Diamyd Medical AB: In-depth analysis of Diamyd® Phase II trial further supports value of preserved insulin secretion | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-24 | Diamyd Medical | Diamyd Medical AB: Fördjupad analys av Fas II-studie med Diamyd® stöder ytterligare värdet av bevarad insulinproduktion | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-24 | Diamyd Medical | Diamyd Medical AB: Quarterly Report I 23/24 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-01-24 | Diamyd Medical | Diamyd Medical AB: Delårsrapport I 23/24 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-01-08 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical gains market research findings to guide U.S. commercial strategy | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-08 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical informerar om marknadsanalys inför kommersiell strategi i USA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-04 | Diamyd Medical | Diamyd Medical AB: Interimsanalys av precisionsmedicinsk fas 3-studie med Diamyd® i juli | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-04 | Diamyd Medical | Diamyd Medical AB: Diamyd® precision medicine Phase 3 trial key interim analysis in July | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-06 | Diamyd Medical | Diamyd Medical AB: Diamyd Medicals precisionsmedicinska patent för förebyggande och behandling av autoimmun diabetes beviljat i Sydkorea | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-06 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical's Precision Medicine patent for the prevention and treatment of autoimmune diabetes granted in South Korea | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-30 | Diamyd Medical | Bulletin from Annual General Meeting of Diamyd Medical AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-30 | Diamyd Medical | Kommuniké från årsstämma i Diamyd Medical AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-29 | Diamyd Medical | Diamyd Medical AB: Annual Report 2022/2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-11-13 | Penser Access | Penser Access: Intervju med Diamyd Medical - Erik Penser Bank - 13 november 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-11-09 | Penser Access | Penser Access: Kassan påfylld - Diamyd Medical | Pressreleaser | Visa Stäng |
|
||||
2023-11-09 | Diamyd Medical | Diamyd Medical AB: Årsredovisning 2022/2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-11-09 | Diamyd Medical | Diamyd Medical AB: Information om årsredovisning 2022/23 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-09 | Diamyd Medical | Diamyd Medical AB: Information about the Annual Report 2022/23 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-07 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical ingår samarbete med DiaUnion för rekrytering till typ 1-diabetes-preventionsstudie | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-07 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical partners with DiaUnion to recruit participants for Type 1 diabetes prevention trial | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-01 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical announces final outcome in the company's rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-01 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical offentliggör slutgiltigt utfall i bolagets företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-31 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical offentliggör preliminärt utfall i bolagets företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-31 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical announces preliminary outcome in the company's rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-31 | Diamyd Medical | Kallelse till årsstämma i Diamyd Medical AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-27 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical offentliggör tilläggsprospekt avseende företrädesemissionen | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-26 | Diamyd Medical | Diamyd Medical AB: Uppföljningsstudie tyder på att Diamyd® kan ge fördelar vad gäller att fördröja typ 1-diabetesdiagnos | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-26 | Diamyd Medical | Diamyd Medical AB: Follow-up study suggests Diamyd® may offer advantages in delaying type 1 diabetes onset | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-26 | Diamyd Medical | Diamyd Medical AB: BioStock: Diamyd Medical om fas III-studien och emissionen | Pressreleaser | Visa Stäng |
|
||||
2023-10-24 | Diamyd Medical | Diamyd Medical AB: BioStock: Emission ska ta Diamyd Medical genom fas III | Pressreleaser | Visa Stäng |
|
||||
2023-10-20 | Diamyd Medical | Diamyd Medical AB: Preliminary results from Booster trial with Diamyd® provide additional support for intralymphatic injections | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-20 | Diamyd Medical | Diamyd Medical AB: Preliminära resultat från booster-studie med Diamyd® ger ytterligare stöd för intralymfatiska injektioner | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-19 | Diamyd Medical | Diamyd Medical AB: BioStock Investor Pitch: Diamyd Medical | Pressreleaser | Visa Stäng |
|
||||
2023-10-18 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical presenterar på BioStock Life Science Summit den 25 oktober | Pressreleaser | Visa Stäng |
|
||||
2023-10-17 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical announces a webcast presentation on October 20 regarding its industry partnership with JDRF | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-17 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical håller en webbsänd presentation den 20 oktober om branschpartnerskapet med JDRF | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-17 | Diamyd Medical | Diamyd Medical AB: BioStock: Diamyd Medicals vd om företrädesemissionen | Pressreleaser | Visa Stäng |
|
||||
2023-10-16 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical publishes prospectus with regards to the rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-16 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical offentliggör prospekt avseende företrädesemissionen | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-12 | Penser Access | Penser Access: Genomför företrädesemission - Diamyd Medical | Pressreleaser | Visa Stäng |
|
||||
2023-10-11 | Diamyd Medical | Diamyd Medical AB: Year-End Report 22/23 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-10-11 | Diamyd Medical | Diamyd Medical AB: Bokslutskommuniké 22/23 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-10-10 | Diamyd Medical | Bulletin from Extra General Meeting of Diamyd Medical AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-10 | Diamyd Medical | Kommuniké från extra bolagsstämma i Diamyd Medical AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-02 | Diamyd Medical | Diamyd Medical AB: Anders Essen-Möller utsedd till styrelseordförande i Diamyd Medical | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-02 | Diamyd Medical | Diamyd Medical AB: Anders Essen-Möller has been appointed Chairman of the Board of Diamyd Medical | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-25 | Penser Access | Penser Access: Intervju med Diamyd Medical - Erik Penser Bank - 25 september 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-09-21 | Diamyd Medical | Kallelse till extra bolagsstämma i Diamyd Medical AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-20 | Diamyd Medical | Diamyd Medical AB: The Board of Directors in Diamyd Medical resolves on a rights issue of approximately SEK 243 million | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-20 | Diamyd Medical | Diamyd Medical AB: Styrelsen i Diamyd Medical beslutar om en företrädesemission om cirka 243 MSEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-05 | Diamyd Medical | Diamyd Medical AB: Registreringsgrundande fas III-studie i typ 1-diabetes med Diamyd® expanderar till USA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-05 | Diamyd Medical | Diamyd Medical AB: Registrational Phase III trial in Type 1 Diabetes with Diamyd® expands to the US | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-16 | Diamyd Medical | Diamyd Medical AB: Resultaten från antigenspecifik immunoterapi i LADA med Diamyd® publicerade i vetenskaplig tidskrift | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-16 | Diamyd Medical | Diamyd Medical AB: Results from Diamyd® Antigen-Specific Immunotherapy Trial in LADA published in scientific journal | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-29 | Penser Access | Penser Access: Klirr i kassan - Diamyd Medical | Pressreleaser | Visa Stäng |
|
||||
2023-06-28 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical announces final outcome in the company's rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-28 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical offentliggör slutgiltigt utfall i bolagets företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-28 | Diamyd Medical | Diamyd Medical AB: Quarterly Report III 22/23 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-06-28 | Diamyd Medical | Diamyd Medical AB: Delårsrapport III 22/23 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-06-27 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical offentliggör preliminärt utfall i bolagets företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-27 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical announces preliminary outcome in the company's rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-26 | Diamyd Medical | Bulletin from Extra General Meeting of Diamyd Medical AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-26 | Diamyd Medical | Kommuniké från extra bolagsstämma i Diamyd Medical AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-19 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical's largest owner fully subscribes for his share in the ongoing rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-19 | Diamyd Medical | Diamyd Medical AB: Diamyd Medicals största ägare tecknar sin andel i pågående företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-14 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical offentliggör tilläggsprospekt avseende företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-13 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical avstår från att göra gällande emissionsgarantiavtalen i företrädesemissionen och förlänger teckningsperioden | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-13 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical refrains from enforcing the underwriting agreements in the rights issue and extends the subscription period | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-09 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical provides an update regarding the ongoing new share issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-09 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical ger en uppdatering avseende den pågående nyemissionen | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-05 | Diamyd Medical | Diamyd Medical AB: Trading in subscription rights in Diamyd Medical's rights issue halted | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-05 | Diamyd Medical | Diamyd Medical AB: Handeln i teckningsrätter i Diamyd Medicals nyemission stoppad | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-05 | Diamyd Medical | Diamyd Medical AB: Handeln i teckningsrätter i Diamyd Medicals företrädesemission inleds i dag | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-01 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical provides supplementary information about the upcoming Extraordinary General Meeting | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-01 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical lämnar kompletterande information om den kommande extra bolagsstämman | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-01 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical offentliggör prospekt avseende företrädesemissionen | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | Diamyd Medical | Kallelse till extra bolagsstämma i Diamyd Medical AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical beslutar om en företrädesemission av aktier om cirka 163 MSEK och kallar till extra bolagsstämma för beslut om emission av teckningsoptioner och ändring av bolagsordningen | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | Diamyd Medical | Diamyd Medical AB: Diamyd Medical resolves on a rights issue of shares of approximately SEK 163 million and convenes an EGM to resolve on an issue of warrants and amendment of the articles of association | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-15 | Penser Access | Penser Access: Intervju med Diamyd Medical - Erik Penser Bank - 15 maj 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-05-11 | Penser Access | Penser Access: Storm i ett vattenglas - Diamyd Medical | Pressreleaser | Visa Stäng |
|
||||
2023-05-10 | Diamyd Medical | Diamyd Medical AB: Topline-resultat från Remygen®-studie i individer med långvarig typ 1-diabetes | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-10 | Diamyd Medical | Diamyd Medical AB: Topline results from Remygen® trial in individuals with long-term Type 1 Diabetes | Pressreleaser | Ladda ner | Visa Stäng |
|